Comments

  • Interesting but I don’t recall seeing any sell advice on chemtrade while it was still above 10. Putting a sell in it now just adds insult to injury.
    Your analysis of stocks in the moderate to higher risk segment has proven to be quite weak over the 10 or so years I have been a subscriber.

    • TSI Research 

      Thanks for your comment. The free Daily headline aimed to draw attention to our coverage of Chemtrade—and our sell recommendation. Please note, though, that for Power Growth Investor subscribers, we updated our advice on Chemtrade—with its sell recommendation—in our November 27, 2020 Power Growth Investor Hotline.

  • Ronald 

    I find your headline alarmist as Chemtrade cut it’s dividend a year ago and so has no bearing on it today. at the time I doubled down on it so I’m still getting the same amount. You seem to like it too for the long run and when conditions improve they may increase the dividend such as Artis is now doing.

    • TSI Research 

      Thanks for your comment. The free Daily headline aimed to draw attention to our coverage of Chemtrade—and our sell recommendation. Please note, though, that for Power Growth Investor subscribers, we updated our advice on Chemtrade—with its sell recommendation—in our November 27, 2020 Power Growth Investor Hotline.

Tell Us What YOU Think

You must be logged in to post a comment.

Please be respectful with your comments and help us keep this an area that everyone can enjoy. If you believe a comment is abusive or otherwise violates our Terms of Use, please click here to report it to the administrator.